Merck & Co., Inc. — Director's Dealing 2021

Jan 7, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-01-01

Reporting Person: Li Dean Y (Executive VP & President, MRL)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7170.093	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit	$	2021-05-04	Common Stock (694)		Direct
Restricted Stock Unit	$	2022-05-03	Common Stock (1500)		Direct
Restricted Stock Unit	$	2023-05-01	Common Stock (3090)		Direct
Stock Option (Right to Buy)	$63.97	2027-05-04	Common Stock (14265)		Direct
Stock Option (Right to Buy)	$57.75	2028-05-03	Common Stock (14638)		Direct
Stock Option (Right to Buy)	$80.00	2029-05-02	Common Stock (16936)		Direct
Stock Option (Right to Buy)	$77.67	2030-04-30	Common Stock (24165)		Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.

F5: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.

F6: The option became exercisable in equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.

F7: The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

F8: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.

F9: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.